Ani immunomodulator Hepon inhibits hepatitis C virus replication in human cell cultures in vitro
Ataullakhanov, R.I.; Holms, R.D.; Katlinskiĭ, A.V.; Deriabin, P.G.; Narovlianskiĭ, A.N.; Mezentseva, M.V.; Ershov, F.I.
Antibiotiki i Khimioterapiia 47(8): 9-11
2002
ISSN/ISBN: 0235-2990 PMID: 12515090 Document Number: 547163
Antiviral activity of immunomodulator "Hepon" was evaluated in human cells culture infected with hepatitis C virus. "Hepon" presence protected human cells SW-13 from cytopathogenic effect of hepatitis C virus. Maximum antiviral effect was demonstrated by "Hepon" at concentration 1 mcg/mL. Control antiviral agent reaferon (interferon alfa-2a) was more potent as vitality protecting agent in the case of SW-13 human cells culture. "Hepon" activity is based on changes of cytokins and interferons spectrum so this immunomodulator is expected to be effective against different viruses including herpes virus and encephalocarditis virus.